A clinical trial of Fuzheng Heying recipe in treatment of severe diabetic foot gangrene

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200006700

Enrollment

Unknown

Registered

2022-10-12

Start date

2022-10-10

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic foot

Interventions

Control group:None

Intervention Group:Fuzheng Heying recipe

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Those who meet the above diagnosis and have unilateral disease; ? Age 40-80 years old, Han nationality, male or female; ? Serum total protein is not less than 40 g/L, and albumin is not less than 21 g/L; ? No intravenous infusion or oral administration of drugs affecting protein synthesis, no use of enteral and parenteral nutrition within the previous month; ? Voluntary participation in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: ?Diabetes with ketoacidosis and malignant hypertension; ?Heart failure, complicated with liver and kidney hematopoietic system diseases; ?Malnutrition caused by other reasons, such as tumor, kidney disease (except diabetic nephropathy), liver cirrhosis, burns; ? Ankle brachial index (ABI) < 0.4, indicating severe ischemic lesions of the lower extremities; ? Patients with type I diabetes; ? Pregnant and lactating women; ? Patients with mental and intellectual abnormalities.

Design outcomes

Primary

Measure	Time frame
Effective rate of wound healing;	—

Secondary

Measure	Time frame
TCM syndrome score;	—

Countries

China

Contacts

Public ContactCao Yemin

dr_cao@163.com+86 13361831119

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026